F. Mach

Discipline

Psychologie (5) Anthropologie biologique (3) Sciences de l'information et de la communication (1) Economies et finances (1)

Type de document

Articles (40)

Co-auteur

Date

Source

Mot-clé

Patients (26) Patients (26) risque (24) Risk (24) Human beings (22) association (19) Social groups (19) Syndromes (18) cohorte (18) âge (14) Year (14) Ci (Chinese poetry) (14) Age (14) Age (14) Older people (13) Myocardial infarction (12) Risk factors (12) mortalité (11) Mortality (11) Treatment (11) Mortality (11) roman (11) maladie cardiovasculaire (10) Confidence (10) Cholesterol (10) danger (9) maladie (9) Prevention (9) Death (9) Rates (9)

Documents écrit par F. Mach (40) | parle de F. Mach (0)

History of peripheral artery disease and cardiovascular risk of real-world patients with acute coronary syndrome: Role of inflammation and comorbidities.
A. Denegri et al. (1 juil. 2023)
Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: A case-cohort analysis.
S. Kraler et al.
« Heart Team » : le cœur de la cardiologie.
F. Mach et al. (24 mai 2023)
Smoking Cessation in People With and Without Diabetes After Acute Coronary Syndrome.
L. Clement et al. (1 janv. 2023)
Smoking cessation and depression after acute coronary syndrome.
K. Krasieva et al.
Long-term effects of systematic smoking cessation counselling during acute coronary syndrome, a multicentre before-after study.
L. Gilgien-Dénéréaz et al. (18 juil. 2022)
Changes of lipoprotein(a) levels with endogenous steroid hormones.
E. Tessitore et al.
Cardiovascular therapy use, modification, and in-hospital death in patients with COVID-19: A cohort study.
C. Follonier et al. (2022)
Symptoms and quality of life at 1-year follow up of patients discharged after an acute COVID-19 episode.
E. Tessitore et al. (6 déc. 2021)
Association between self-reported motivation to quit smoking with effectiveness of smoking cessation intervention among patients hospitalized for acute coronary syndromes in Switzerland.
I. Worni-Schudel et al.
Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes.
R. Klingenberg et al. (19 oct. 2021)
CCN family member 1 (CCN1) is an early marker of infarct size and left ventricular dysfunction in STEMI patients.
T. Mahendiran et al.
ARN : du prix Nobel au traitement, la cardiologie au devant de la scène [Not Available]
F. Mach et al. (26 mai 2021)
Novel Blood Biomarkers for a Diagnostic Workup of Acute Aortic Dissection.
A. Forrer et al. (30 mars 2021)
Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events.
R. Klingenberg et al.
Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
S. Barco et al. (9 sept. 2020)
Prognostic and therapeutic considerations of antibodies against c-ter apolipoprotein A-1 in the general population.
N. Vuilleumier et al. (2020)
Optimal Timing of Invasive Coronary Angiography following NSTEMI.
T. Mahendiran et al. (2020)
Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61.
P. Winzap et al. (31 oct. 2019)
Non-Linear Relationship between Anti-Apolipoprotein A-1 IgGs and Cardiovascular Outcomes in Patients with Acute Coronary Syndromes.
N. Vuilleumier et al. (9 juil. 2019)
Association between income and control of cardiovascular risk factors after acute coronary syndromes: an observational study.
E. Jaquet et al. (8 avr. 2019)
Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention.
D. Carballo et al. (2019)
Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST-Elevation Myocardial Infarction.
K.C. Koskinas et al. (13 avr. 2018)
Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome.
S. Canivell et al. (2018)
Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population.
P. Antiochos et al.

next